Corami Welcomes Biomaterials Engineer, Evan Main, Ph.D.

Corami Biotech is pleased to welcome Evan Main, Ph.D., to the team as a Biomaterials Engineer supporting the development and optimization of our hydrogel technology.

Evan earned his Ph.D. in Biomedical Engineering from the University of Memphis, where his research focused on cardiovascular tissue engineering, biomaterial fabrication, and drug delivery approaches designed to improve post-surgical outcomes.

His expertise in biomaterials and cardiovascular applications will support Corami's ongoing development of localized therapeutic delivery systems for the heart.

View the original announcement on LinkedIn

Corami Biotech Inc.

Corami Biotech Inc. is a biotechnology company developing localized cardiac therapeutic delivery systems designed to improve treatment effectiveness while reducing systemic exposure.

https://www.coramibio.com
Next
Next

Corami Biotech Expands Across Memphis and Emory Innovation Hubs